0001209191-16-092049.txt : 20160119 0001209191-16-092049.hdr.sgml : 20160118 20160119161812 ACCESSION NUMBER: 0001209191-16-092049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160114 FILED AS OF DATE: 20160119 DATE AS OF CHANGE: 20160119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerulean Pharma Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 5TH FLOOR CITY: Cambridge STATE: MA ZIP: 02139 BUSINESS PHONE: 617-551-9600 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 5TH FLOOR CITY: Cambridge STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WALT DAVID R CENTRAL INDEX KEY: 0001205236 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 161348516 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-14 0 0001401914 Cerulean Pharma Inc. CERU 0001205236 WALT DAVID R C/O CERULEAN PHARMA INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451 1 0 0 0 Common Stock 2016-01-14 4 P 0 4400 2.6427 A 67031 D Common Stock 2016-01-15 4 P 0 4172 2.4169 A 71203 D These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2015. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.60 to $2.70 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.33 to $2.51 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. /s/ Alejandra Carvajal, as attorney-in-fact for David R. Walt 2016-01-19